OCULAR MELANOMA
Clinical trials for OCULAR MELANOMA explained in plain language.
Never miss a new study
Get alerted when new OCULAR MELANOMA trials appear
Sign up with your email to follow new studies for OCULAR MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Light-Activated drug could halt rare eye cancer growth
Disease control Recruiting nowThis study tests a new drug called belzupacap sarotalocan (AU-011) for people with a rare eye cancer (choroidal melanoma) or suspicious spots that could turn into cancer. The drug is activated by a laser to target and destroy cancer cells. About 100 participants will receive eith…
Matched conditions: OCULAR MELANOMA
Phase: PHASE3 • Sponsor: Aura Biosciences • Aim: Disease control
Last updated May 16, 2026 23:50 UTC
-
New drug combo aims to boost immune attack on tough melanoma
Disease control Recruiting nowThis early-stage trial tests a new drug (IOV-3001) combined with an immune cell therapy (lifileucel) in adults with advanced melanoma that has stopped responding to standard treatments. The goal is to find a safe dose and see if the combination can help control the disease. About…
Matched conditions: OCULAR MELANOMA
Phase: PHASE1, PHASE2 • Sponsor: Iovance Biotherapeutics, Inc. • Aim: Disease control
Last updated May 07, 2026 18:42 UTC
-
New combo aims to shrink Hard-to-Treat eye cancer
Disease control Recruiting nowThis study tests whether combining two drugs, olaparib and pembrolizumab, can shrink tumors or slow the disease in people with advanced uveal melanoma, a rare eye cancer that has spread. About 37 adults with this condition will receive the combination treatment. The goal is to se…
Matched conditions: OCULAR MELANOMA
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 07, 2026 18:41 UTC
-
Eye cancer Patients' Well-Being under the microscope
Knowledge-focused Recruiting nowThis study looks at how choroidal melanoma and its treatment affect daily life and well-being. It involves 15 people already in a larger Phase 3 trial. Participants fill out questionnaires about their quality of life over two years. No new drugs or procedures are tested here.
Matched conditions: OCULAR MELANOMA
Sponsor: Aura Biosciences • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC